# GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial

Study · id `cardio:ct-nct07613437` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07613437](<https://clinicaltrials.gov/study/NCT07613437>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07613437

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07613437. Randomized; no masking; primary purpose treatment. Start 2026-06-15 (anticipated); primary completion 2028-06-14 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07613437, source copy `cardio:ctgov-nct07613437-2026-05-29`, retrieved 2026-10-31)
- Planned start: 2026-06-15 (anticipated) (ClinicalTrials.gov record NCT07613437, source copy `cardio:ctgov-nct07613437-2026-05-29`, retrieved 2026-10-31)
- Primary completion: 2028-06-14 (anticipated) (ClinicalTrials.gov record NCT07613437, source copy `cardio:ctgov-nct07613437-2026-05-29`, retrieved 2026-10-31)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07613437, source copy `cardio:ctgov-nct07613437-2026-05-29`, retrieved 2026-10-31)
- Countries: China; Hong Kong SAR China (ClinicalTrials.gov record NCT07613437, source copy `cardio:ctgov-nct07613437-2026-05-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07613437-2026-05-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
- Acronym: GLICH
- Condition: Intracerebral Hemorrhage
- Intervention (Drug): Semaglutide, 0.5 mg/mL
- Lead sponsor: Chinese University of Hong Kong
- Lead sponsor class: OTHER
- Collaborator: The First Affiliated Hospital of University of Science and Technology of China
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Wenzhou Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Semaglutide (`cardio:semaglutide`)
- Registry intervention is a member of this class by a sourced record link: GLP-1 receptor agonists (drug class) (`cardio:glp1-receptor-agonists`)
- Registry lists this organization as the lead sponsor: Chinese University of Hong Kong (`cardio:org-chinese-university-of-hong-kong`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital of University of Science and Technology of China (`cardio:org-the-first-affiliated-hospital-of-university-of-science-and-03d159`)
- Registry lists this organization as a collaborator: First Affiliated Hospital of Wenzhou Medical University (`cardio:org-first-affiliated-hospital-of-wenzhou-medical-university`)

## Provenance

Content hash: 24f198c5bdc4a12e89ddc9947a7d58577d502b7b7a2606a40aa56a59d989e369
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
